You can enrol in up to 20 courses during temporary access. You’ve reached this limit and can’t enrol in any more right now.
Once you have full access, you’ll be able to enrol without limit.
![]()
The benefits or oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 Watch this short video to learn more about the benefits of HMB.
Prescribe or recommend nutritional support containing HMB for your patients today.

Ensure Plus Advance
Ensure Plus Advance is a 220 ml, ready-to-drink, oral nutritional supplement (ONS) formulated specifically for older adults who have, or are at risk of, malnutrition. It’s our most advanced ONS yet, with each bottle providing 330 kcal (1.5 kcal/ml), 20 g of protein, 13 μg of vitamin D (500 IU), 499 mg of calcium and 1.5g of CaHMB (calcium-β-hydroxy-β-methylbutyrate).
Ensure Plus Advance is available in 5 delicious flavours: banana, chocolate, coffee, strawberry and vanilla.

Jevity Advance
Jevity Advance is a 1.5kcal/ml, nutritionally complete† tube feed with FOS (fructo-oligosaccharides), and a unique blend of high protein, additional vitamin D and CaHMB (calcium-β-hydroxy-β-methylbutyrate). Jevity Advance is available in 500 ml Ready to Hang bottles, which attach directly to Abbott giving sets.

The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.
Footnotes:
† HMB (Beta-hydroxy-beta-methylbutyrate) is an active metabolite of leucine, among the constituent elements of proteins, naturally found in some foods, but in small quantities.
* Studied in healthy young males, over a period of 2.5 hours after receiving HMB supplementation.
°Compared to baseline at post-absorptive state.
**In a RCT including 19 healthy adults aged ≥60 years confined to bed rest for 10 days. CaHMB (3 g daily) prevented the decline in total LBM over bed rest (-0.17 ± 0.19 kg; p =0.23) in treated group versus control group (-2.05±0.66 kg; p =0.02)
# In a single arm open-label study of 148 patients aged 80±8.3 years with or at risk of malnutrition who consumed experimental product twice daily for 12 weeks as compared to baseline.
† An open label study of elderly (n = 35) patients with recent weight loss (>5% during previous 3 months) showed that 12 weeks supplementation of experimental product twice daily increased dietary intake, biochemical variables, and quality of life compared to baseline
‡In 62 community-dwelling pre-frail older people taking a specialised ONS vs nutritional counselling over 12 weeks.
References:
1. Carbone JW & Pasiakos SM. Nutrients 2019;11(5):1136. 2. Tipton KD et al. Sports Med 2018;48(1):53-64. 3. Argilés JM et al. J Am Med Dir Assoc 2016;17(9):789-96. 4. Wilkinson DJ et al. J Physiol 2013;591:2911-23. 5. Deutz NE et al. Clin Nutr 2014;33(6):929-936. 6. Holeček m et al. J Cachexia Sarcopenia Muscle 2017;8(4):529-541. 7. Arazi H et al. Antioxidants (Basel) 2018;7(10):148. 8. Bear DE et al. Am J Clin Nutr 2019;109:1119-1132. 9. Peng LN et al. J Nutr Health Aging 2021;25(6):767-773. 10. Ashkenazi I et al. Geriatr Orhop Surg Rehabil DOI: 10.1177/21514593221102252 Published online 22nd May 2022. 11. Berton L et al. PLoS one 2015;10(11):e0141757. 12. Chavarro-Carvajal DA et al. Clin Nutr ESPEN 2022;48:291-297. 13. Cornejo-Pareja I et al. Nutrients 2021;13(12):4355. 14. Cramer JT et al. JAMDA; 2016;17(11):1044-1055. 15. De Luis DA et al. Eur Geriatr Med 2018;9(6):809-817. 16. De Luis DA et al. Nutr Hosp 2015;32(1):202-207. 17. Deutz NE et al. Clin Nutr 2016;35(1):18-26. 18. Deutz NE et al. Clin Nutr 2021;40(3):1388-1395. 19. Ekinci O et al. Nutr Clin Pract 2016;31(6):829-835. 20. Espina S et al. Nutrients 2021;13(11):3764. 21. Matheson EM et al. Clin Nutr 2021;40(3):844-849. 22. Malafarina V et al. Maturitas 2017;101:42-50. 23. Olveira G et al. Clin Nutr 2016;35(5):1015-1022. 24. Previtali P et al. Ann Surg Oncol 2020;27(6):2025-2032. 25. Ritch CR et al. J Urol 2019;201(3):470-477. 26. Standley RA et al. J Gerontol A Bio Sci Med Sci 2020;75(9):1744-1753. 27. Zana S et al. J Am Med Dir Assoc 2021;22(7):1358-1360. 28. Zhang Z et al. FASEB J 1994;8(4):A464, Abstr 2685. 29. Nissen SL & Abumrad NN. J Nutr Biochem 1997;8:300-311. 30. Engelen MPKJ & Deutz NEP. Curr Opin Clin Nutr Metab Care 2018;21(3):207-213. 31. Deutz NEP et al. Clin Nutr 2013;32:704-712.
SESSION TIMEOUT
Please log in to continue
Thanks for registering. To begin, please log in to your ProConnect account. After you log in, you’ll have temporary access to all resources and education while we verify your details.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
| Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your account has not yet been approved. We’re validating your credentials. You won’t be able to order samples until your account is approved and activated. Please check your email for more details. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
You have {liteUserDaysLeft} business days of temporary access.
Based on your email address {email} your credentials are validated but not yet activated. To gain full access, including the ability to order samples, click the activation link we sent to your inbox. For help, contact us at abbott.proconnect_access@nhs.net.
UK--2500192 | September 2025
Register to continue reading this article
UK-N/A-2400058(v9) | September 2025
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.